Significance of cytokines and CD68‐positive microparticles in immune thrombocytopenic purpura
- 1 July 1995
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 55 (1) , 49-56
- https://doi.org/10.1111/j.1600-0609.1995.tb00232.x
Abstract
We investigated the significance of cytokines (soluble interleukin‐2 receptor, granulocyte‐macrophage colony‐stimulating factor, interleukin‐6, and interferon‐gamma) and CD68‐positive microparticles in immune thrombocytopenic purpura. Cytokines were measured by enzyme‐linked immunosorbent assay and microparticles were detected by flow cytometry. CD68 expression by histiocytic U937 cells incubated with lipopolysaccharide or cytokines was also assessed in a control study. The level of CD68‐positive microparticles was significantly higher in the patients with thrombocytopenia than in normal controls (p<0.01). The soluble interleukin‐2 receptor level was also significantly higher in patients than in controls (p20000/μl) had significantly higher levels of granulocyte‐macrophage colony‐stimulating factor and interleukin‐6 than the controls (p<0.05). When opsonized platelets were incubated with activated U937 cells, lipopolysaccharide and granulocyte‐macrophage colony‐stimulating factor caused an increase of CD68‐positive microparticles in the supernatant. These results suggest that granulocyte‐macrophage colony‐stimulating factor is released by activated T cells in immune thrombocytopenic purpura and activates monocyte/macrophage phagocytosis, resulting in an increase of circulating CD68‐positive microparticles and enhanced platelet destruction.Keywords
This publication has 47 references indexed in Scilit:
- Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpuraBritish Journal of Haematology, 1993
- Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpuraAnnals of Hematology, 1992
- Anti-Glycoprotein Iib/Iiia Autoantibodies are Reversibly Internalized Into Platelets in Idiopathic (Autoimmune) Thrombocytopenic PurpuraAutoimmunity, 1992
- Interleukin-6 in clinical medicineAnnals of Hematology, 1991
- Antiplatelet autoantibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpuraAnnals of Hematology, 1991
- Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseasesClinical Immunology and Immunopathology, 1989
- Soluble interleukin‐2 receptors in systemic lupus erythematosusArthritis & Rheumatism, 1988
- Expression of the macrophage specific colony-stimulating factor (CSF-1) during human monocytic differentiationBiochemical and Biophysical Research Communications, 1986
- T Lymphocyte Subpopulations in Idiopathic Thrombocytopenic Purpura (ITP)Scandinavian Journal of Haematology, 1983
- Chronic Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1981